Cancer Biomarkers: Clinical Aspects and Laboratory Determination: Clinical Aspects and Laboratory Determination
Editat de Lakshmi V. Ramanathan, Martin Fleisher, Michael J. Duffyen Limba Engleză Paperback – 15 iun 2022
This title is a perfect reference for clinical pathologists, laboratory scientists, medical technologists, physicians specializing in oncology, internal medicine, family practice and transplant medicine, resident physicians, medical students, nurse practitioners and clinical chemists.
- Provides insights into the overall complexity that the cancer patient presents and how laboratory tests are used in the management of care
- Discusses current and new technologies applicable to cancer biomarker evaluation, including the use of non-traditional specimens like saliva, fluids and uterine lavage
- Reviews current trends in liquid biopsy and cancer biomarkers
- Provides a roadmap for bringing new technologies and markers from the bench to the bedside in the quest for finding the ideal tumor marker
Preț: 747.99 lei
Preț vechi: 973.81 lei
-23% Nou
Puncte Express: 1122
Preț estimativ în valută:
143.16€ • 148.90$ • 119.97£
143.16€ • 148.90$ • 119.97£
Carte tipărită la comandă
Livrare economică 06-20 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128243022
ISBN-10: 0128243023
Pagini: 474
Dimensiuni: 191 x 235 x 32 mm
Greutate: 0.95 kg
Editura: ELSEVIER SCIENCE
Seria Clinical Aspects and Laboratory Determination
ISBN-10: 0128243023
Pagini: 474
Dimensiuni: 191 x 235 x 32 mm
Greutate: 0.95 kg
Editura: ELSEVIER SCIENCE
Seria Clinical Aspects and Laboratory Determination
Public țintă
Clinical pathologists; laboratory scientists; medical technologists; physicians specializing in oncology, internal medicine, family practice and transplant medicine; resident physicians; medical students; nurse practitioners, clinical chemistsCuprins
1. Overview of tumor markers, traditional and non-traditional (include glycans)
2. Laboratory testing in pediatric cancer patients
3. The adult cancer patient: overview and current laboratory testing
4. Thyroglobulin measurement: its importance in monitoring and recurrence of thyroid cancer
5. PSA, long term prognosis
6. Monoclonal gammopathy detection and current technologies
7. Liquid biopsy potential and challenges
8. CAR T therapies and the management of toxicity
9. Validating circulating tumor cells and cell free DNA as an LDT for use in the clinic
10. Saliva as a matrix for measurement of biomarkers
11. Emerging technologies in the detection and monitoring of cancer
12. Oncometabolites
13. Circulating cancer biomarkers: current status and future prospects
2. Laboratory testing in pediatric cancer patients
3. The adult cancer patient: overview and current laboratory testing
4. Thyroglobulin measurement: its importance in monitoring and recurrence of thyroid cancer
5. PSA, long term prognosis
6. Monoclonal gammopathy detection and current technologies
7. Liquid biopsy potential and challenges
8. CAR T therapies and the management of toxicity
9. Validating circulating tumor cells and cell free DNA as an LDT for use in the clinic
10. Saliva as a matrix for measurement of biomarkers
11. Emerging technologies in the detection and monitoring of cancer
12. Oncometabolites
13. Circulating cancer biomarkers: current status and future prospects